HCPCS Level II drug code
J7507 — Tacrolimus, immediate release, oral, 1 mg
In short
J7507 is the HCPCS Level II code for tacrolimus, immediate release, oral, 1 mg. CMS assigns NDCs for Prograf, Tacolimus and Tacrolimus to it. One billing unit is 1 mg. The Medicare Part B payment limit is $0.162 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Tacrolimus, immediate release, oral, 1 mg
- Short descriptor
- Tacrolimus imme rel oral 1mg
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2014
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Units = dose given ÷ 1 mg. For example, 100 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
NDCs billed under J7507
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 40 NDCs to J7507 for Prograf, Tacolimus and Tacrolimus. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Prograf | 00469-0607-73 | Astellas Pharma US, Inc. | 100 | 50 |
| Prograf | 00469-0617-73 | Astellas Pharma US, Inc. | 100 | 100 |
| Prograf | 00469-0657-73 | Astellas Pharma US, Inc. | 5 × 100 | 500 |
| Tacolimus | 82009-0164-01 | Quallent Pharmaceuticals | 100 | 50 |
| Tacrolimus | 00378-2045-01 | Mylan Pharmaceuticals Inc. | 100 | 50 |
| Tacrolimus | 00378-2046-01 | Mylan Pharmaceuticals Inc. | 100 | 100 |
| Tacrolimus | 00378-2047-01 | Mylan Pharmaceuticals Inc. | 100 | 500 |
| Tacrolimus | 00781-2102-01 | Sandoz Inc. | 100 | 50 |
| Tacrolimus | 00781-2103-01 | Sandoz Inc. | 100 | 100 |
| Tacrolimus | 00781-2104-01 | Sandoz Inc. | 100 | 500 |
| Tacrolimus | 00904-7097-61 | Major Pharmaceuticals | 100 | 100 |
| Tacrolimus | 16714-0098-01 | Northstar RxLLC | 100 | 50 |
| Tacrolimus | 16714-0099-01 | Northstar RxLLC | 100 | 100 |
| Tacrolimus | 16714-0100-01 | Northstar RxLLC | 100 | 500 |
| Tacrolimus | 16729-0041-01 | Accord Healthcare Inc | 100 | 50 |
| Tacrolimus | 16729-0042-01 | Accord Healthcare Inc | 100 | 100 |
| Tacrolimus | 16729-0043-01 | Accord Healthcare Inc | 100 | 500 |
| Tacrolimus | 50090-5581-00 | A-S Medication Solutions | 90 | 90 |
| Tacrolimus | 50090-5596-00 | A-S Medication Solutions | 90 | 90 |
| Tacrolimus | 55111-0525-01 | Dr. Reddy's Laboratories Inc. | 100 | 50 |
| Tacrolimus | 55111-0526-01 | Dr. Reddy's Laboratories Inc. | 100 | 100 |
| Tacrolimus | 55111-0527-01 | Dr. Reddy's Laboratories Inc. | 100 | 500 |
| Tacrolimus | 64380-0720-06 | Strides Pharma Science Limited | 100 | 50 |
| Tacrolimus | 64380-0721-06 | Strides Pharma Science Limited | 100 | 100 |
| Tacrolimus | 64380-0722-06 | Strides Pharma Science Limited | 100 | 500 |
| Tacrolimus | 67877-0278-01 | Ascend Laboratories, LLC | 100 | 50 |
| Tacrolimus | 67877-0279-01 | Ascend Laboratories, LLC | 100 | 100 |
| Tacrolimus | 67877-0280-01 | Ascend Laboratories, LLC | 100 | 500 |
| Tacrolimus | 68084-0449-01 | American Health Packaging | 100 | 50 |
| Tacrolimus | 68084-0450-01 | American Health Packaging | 100 | 100 |
| Tacrolimus | 68084-0451-01 | American Health Packaging | 100 | 500 |
| Tacrolimus | 68462-0685-01 | Glenmark Pharmaceuticals Inc., USA | 100 | 50 |
| Tacrolimus | 68462-0686-01 | Glenmark Pharmaceuticals Inc., USA | 100 | 100 |
| Tacrolimus | 68462-0687-01 | Glenmark Pharmaceuticals Inc., USA | 100 | 500 |
| Tacrolimus | 70377-0014-11 | Biocon Pharma Inc | 100 | 50 |
| Tacrolimus | 70377-0015-11 | Biocon Pharma Inc | 100 | 100 |
| Tacrolimus | 70377-0016-11 | Biocon Pharma Inc | 100 | 500 |
| Tacrolimus | 72572-0760-01 | Civica, Inc. | 100 | 50 |
| Tacrolimus | 72572-0761-01 | Civica, Inc. | 100 | 100 |
| Tacrolimus | 82009-0054-01 | Quallent Pharmaceuticals | 100 | 100 |
J7507: common questions
- Is J7507 a CPT code?
- No. J7507 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J7507?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 40 NDCs under J7507, for Prograf, Tacolimus and Tacrolimus. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J7507?
- $0.162 per 1 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
- What is one billing unit of J7507?
- One unit of J7507 is 1 mg, as stated in the code's descriptor. Units to report = dose given ÷ 1 mg. J-code billing units.